INDICATIONS
Fexofenadine HCl is indicated for the relief of
symptoms associated with seasonal allergic rhinitis in adults
and children 12 years of age and older. Symptoms treated
effectively include sneezing, rhinorrhea, itchy nose/palate/throat,
itchy/watery/red eyes.
DOSAGE AND ADMINISTRATION
Seasonal Allergic Rhinitis
Adults and Children 12 Years and Older. The recommended
dose of ALLEGRA is 60 mg twice daily, or 180 mg once daily.
A dose of 60 mg once daily is recommended as the starting
dose in patients with decreased renal function (see CLINICAL
PHARMACOLOGY ).
Children 6 to 11 Years. The recommended dose of ALLEGRA
is 30 mg twice daily. A dose of 30 mg once daily is recommended
as the starting dose in pediatric patients with decreased
renal function (see CLINICAL PHARMACOLOGY ).
Chronic Idiopathic Urticaria
Adults and Children 12 Years and Older. The recommended
dose of ALLEGRA is 60 mg twice daily. A dose of 60 mg once
daily is recommended as the starting dose in patients with
decreased renal function (see CLINICAL PHARMACOLOGY ).
Children 6 to 11 Years. The recommended dose of ALLEGRA
is 30 mg twice daily. A dose of 30 mg once daily is recommended
as the starting dose in pediatric patients with decreased
renal function (see CLINICAL PHARMACOLOGY ).
HOW SUPPLIED
ALLEGRA 30 mg tablets are available in: high-density
polyethylene (HDPE) bottles of 100 (NDC 0088-1106-47) with
a polypropylene screw cap containing a pulp/wax liner with
heat-sealed foil inner seal and HDPE bottles of 500 (NDC
0088-1106-55) with a polypropylene screw cap containing
a pulp/wax liner with heat-sealed foil inner seal.
ALLEGRA 60 mg tablets are available in: HDPE bottles of
100 (NDC 0088-1107-47) with a polypropylene screw cap containing
a pulp/wax liner with heat-sealed foil inner seal; HDPE
bottles of 500 (NDC 0088-1107-55) with a polypropylene screw
cap containing a pulp/wax liner with heat-sealed foil inner
seal; and aluminum foil-backed clear blister packs of 100
(NDC 0088-1107-49).
ALLEGRA 180 mg tablets are available in: HDPE bottles of
100 (NDC 0088-1109-47) with a polypropylene screw cap containing
a pulp/wax liner with heat-sealed foil inner seal; and HDPE
bottles of 500 (NDC 0088-1109-55) with a polypropylene screw
cap containing a pulp/wax liner with heat-sealed foil inner
seal.
ALLEGRA tablets are coated with a peach colored film coating.
Tablets have the following unique identifiers: 30 mg tablets
have 03 on one side and either 0088 or scripted E on the
other; 60 mg tablets have 06 on one side and either 0088
or scripted E on the other; and 180 mg tablets have 018
on one side and either 0088 or scripted E on the other.
Store ALLEGRA tablets at controlled room temperature 20-25°C
(68-77°F). (See USP Controlled Room Temperature). All
tablet packaging should be protected from excessive moisture.
Note: Allegra capsules (60mg) discontinued Feb 2002.
|
|
